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Corticosteroid-induced Dercum’s diseaseCase report
A 37-year-old woman presented with progressive generalized
tightening of the skin affecting the face, upper back and proximal
arms for 6 years. She was initially diagnosed as scleroderma at
the rheumatological department. Because of poor treatment
response to cyclophosphamide and methylprednisolone, skin
biopsy was performed in the dermatological department. Based
on presence of irregularly oriented and separated collagen ﬁbers
with mucin deposition in the dermis, scleromyxedema was diag-
nosed. She received intravenous immune globulin, 24 g/day for 5
consecutive days, and intravenous methylprednisolone, 500 mg/
month for 4 months. Subsequently, prednisone (20 mg/day) was
given for maintenance. Her scleromyxedema improved gradually.
However, during the course of 1 year there was a gradual onset of
painful subcutaneous masses developing on the bilateral upper
arms, and her weight increased from 54 kg to 70 kg. The pain was
stabbingwithout radiation and persisted almost all day. The patient
also complained of muscle weakness and fatigability, and the clin-
ical impression at that time was musculoskeletal involvement of
scleromyxedema. In addition, the patient developed depression,
insomnia, and mood irritability, and was diagnosed with major
depressive disorder. Oral quetiapine 275 mg, mirtazapine 60 mg,
and zolpidem 20 mg at bedtime were added to her treatment
regimen. Family history was negative for lipomatosis.
On physical examination, soft, well-circumscribed subcuta-
neous masses with nodular swelling were found on both upper
arms (Figure 1). In addition, tachycardia (112 beats/minute)
and abdominal bloating without shifting dullness were noted.
Neurological examination was unremarkable. Laboratory investi-
gations revealed a white blood cell count of 10.7109/L (normalFigure 1 (A) Nodular swelling of bilateral upper a
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range¼ 42–74%). Fasting blood glucose, renal function tests, liver
function tests, serum lipids (cholesterol and triglyceride), free T4,
thyroid stimulating hormone, and adrenocorticotropine hormone
were all within normal limits. Soft tissue ultrasound over the upper
arms showed adipose tissue hypertrophy (Figure 2A).
We performed incisional biopsy on her right upper arm. The
pathology revealed a lobulated lipoma composed of univacuolated
mature adipocytes. The following features such as inﬂammation,
abnormal vascularity, necrosis, ﬁbrosis, or microthrombi were not
found (Figure 2B). Based on clinical history and pathological ﬁnd-
ings, corticosteroid-induced Dercum’s disease (adiposis dolorosa)
was diagnosed.
Discussion
Dercum’s disease is a rare disorder characterized by diffuse or local-
ized painful fatty deposits, occurring primarily in postmenopausal,
obese women of middle age.1,2 Fatty deposits can be found in
almost any location. There are three subtypes of Dercum’s disease:
juxta-articular, diffuse/generalized, and lipomatosis (nodular). The
essential features of Dercum’s disease include four cardinal symp-
toms: (1) multiple, painful, fatty masses; (2) generalized obesity;
(3) weakness and fatigability; and (4) mental disturbances, which
can include emotional instability, depression, epilepsy, confusion,
and dementia.3,4 Pain can be continuous or paroxysmal, and
worsens with movement. Most reported cases of Dercum’s disease
are sporadic, but there is some evidence that it can be transmitted
as an autosomal dominant trait with incomplete penetrance.4 The
etiology of this disease remains unknown. Dercum’s disease is
a complex and underdiagnosed painful syndrome that may affectrms near shoulders. (B) Close-up lateral view.
. Published by Elsevier Taiwan LLC. All rights reserved.
Figure 2 (A) Soft tissue ultrasound over her upper right arm showed adipose tissue hypertrophy (indicated by two yellow cross symbols, the thickness of subcutaneous fat was
2.63 cm). (B) The pathology revealed a lobulated lipoma composed of univacuolated mature adipocytes without inﬂammation, abnormal vascularity, necrosis, ﬁbrosis, or micro-
thrombi. (H&E, original 20 and inserted 200).
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pain in Dercum’s disease without having any effects on the size of
the fatty lesions.5
Dercum’s disease is a diagnosis of exclusion. Differential diag-
nosis includes other lipomatoses, Cushing’s syndrome, and ﬁbro-
myalgia.2,4 Madelung’s disease, familial lipomatosis syndrome,
and congenital lipomatosis can be differentiated from Dercum’s
disease by the lack of pain associatedwith the lipomas. The adreno-
corticotropine hormone level is low in Cushing’s syndrome but
normal in Dercum’s disease, and pain and nodular swelling are
not typical signs of Cushing’s syndrome. Pain in Dercum’s disease
is associated with the fatty deposits, which is not observed in
ﬁbromyalgia.
To the best of our knowledge, only one case of corticosteroid-
induced Dercum’s disease has been reported in a 67-year-old
female who suffered from eosinophilia–myalgia syndrome.
Grouped, painful lipomas developed after 12 weeks of systemic
corticosteroid treatment.6 Despite its rarity, the development of
Dercum’s disease during the course of treatment for scleromyxe-
dema deserves more attention. It may be misdiagnosed as Cush-
ing’s syndrome or be mistaken for musculoskeletal involvement
of scleromyxedema, as 90% of scleromyxedema patients report
arthralgia, myalgia, or muscle weakness.7,8 Early diagnosis of Der-
cum’s disease is imperative because of the difﬁculties in effective
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